Skip to content

Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions

Paraorbital-Occipital Alternating Current Stimulation Therapy of Patients With Post-Chiasmatic Lesions

Status
Completed
Phases
Phase 2
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01418820
Enrollment
32
Registered
2011-08-17
Start date
2011-03-31
Completion date
2013-12-31
Last updated
2019-07-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Complete Hemianopia, Incomplete Hemianopia, Scotoma, Quadrantanopia, Stroke, Hemorrhage, Brain Trauma

Keywords

hemianopia, visual field defect, stroke, non-invasive brain stimulation, alternating current stimulation

Brief summary

Visual field areas, which are not absolutely blind, are hypothesized to have some residual capacities that constitute their potential for vision restoration. Vision restoration can be achieved by varies methods including behavioral training and electrical brain stimulation such as transcranial direct current stimulation (tDCS) and repetitive transorbital alternating current stimulation (rtACS) which are able to influence the excitability and activity of cortical areas. It is hypothesized that transorbital alternating current stimulation (tACS) can improve the residual field of vision in patients with post-chiasmatic lesions.

Interventions

DEVICEVerum stimulation

10 days (2x 5 working days), daily transorbital alternating current stimulation (rtACS) is applied with a device generating weak current pulses in predetermined firing bursts of 2 to 9 pulses. The amplitude of each current pulse is below 1000 µA. Current intensity is individually adjusted according to how well patients perceived phosphenes, e.g. any sensation of flickering light in response to the rtACS stimulation. Stimulation frequencies were between the individual alpha frequency peak and below flicker fusion.

10 days (2x 5 working days), daily sham-stimulation with the same electrode montage set-up that is used for verum transorbital alternating current stimulation (rtACS). Minimal sham-stimulation was performed with single bursts (approx. one per min) of electrical currents at a given frequency of 5Hz and individually adjusted current amplitude.

Sponsors

EBS Technologies GmbH
CollaboratorINDUSTRY
University of Magdeburg
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* lesion of the tractus opticus or of the visual cortex * lesion age \> 6 months * stable visual field defect with residual vision

Exclusion criteria

* electric or electronic implants, e.g. heart pacer * any metal artefacts in the head * Epilepsy * Auto-immune diseases in acute stage * mental diseases, e.g. schizophrenia etc. * diabetic retinopathy * addictive diseases * blood pressure above 160/100 mmHg * instable or high level of intraocular pressure above 27 mmHg * retinitis pigmentosa * pathological nystagmus * presence of an un-operated tumor or tumor relapse (patients with non-progressive tumor are eligible if study participation is recommended by medical authorities) * focal findings in EEG or photosensitivity (patients with single seizure more than 10 yrs ago may participate) * recurrent transitional ischemic attacks after stroke * arteriosclerosis of large blood vessels with stenosis \>75% * severe coronary heart disease (CHD) * unstable angina pectoris * diabetes with blood glucose level \> 9 mmol/l * myocard infarct/ cardiomyopathy * ventricular fibrillation * risk of vascular thrombosis * pregnant or breast-feeding women

Design outcomes

Primary

MeasureTime frameDescription
detection accuracy (%) in visual field measures over baselinebaseline to 8 weeks after stimulationvisual stimuli detection accuracy in residual and absolutely defect visual field will be assessed using computer-based high resolution perimetry (HRP)

Secondary

MeasureTime frameDescription
detection accuracy (%) in the intact visual field over baselinebaseline to 8 weeks after stimulationvisual stimuli detection accuracy in the intact visual field will be assessed using computer-based high resolution perimetry (HRP)
visual acuity (LogRAD)baseline to 8 weeks after stimulation
EEG parametersbaseline to 8 weeks after stimulationentrainment of stimulation frequencies (EEG power spectra) and measures of functional connectivity
conventional perimetrybaseline to 8 weeks after stimulationvisual fields obtained by static and kinetic perimetry (average threshold in db, average excentricity in degrees)
reaction time (ms)baseline to 8 weeks after stimulationaverage reaction time in ms, measured by computer-based high resolution perimetry (HRP)

Countries

Germany

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 15, 2026